FDA Says Hi-Tech Forfeited Exclusivity; Way Paved for Approval of All Cosopt ANDAs
November 7, 2008Reproduced with permission from Pharmaceutical Law & Industry Report, Vol. 6, p. 1260. Copyright 2008 - The Bureau of National Affairs, Inc.
Obvious-to-try Obviousness Of Chemical Enantiomers In View Of Pre- and Post-KSR Analysis
July 2008Journal of the Patent and Trademark Office Society
By: Jonathan M. Spenner, Ph.D.
Congress Debates The Future Of Generic Biologics
September 2007Corporate Counsel
By: Steven H. Sklar